CompaniesCytes Biotechnologies

Cytes Biotechnologies

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

240

By Phase

PHASE4: 1

By Status

COMPLETED: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
Today
NCT03743896
Hover over trial bars to see details

Recent Trials

NCT03743896Lead Sponsor
Transdermal Delivery of Glucosamine to the Synovial Fluid of Male and Female With Knee Osteoarthritis
PHASE4Completed
240 participants
Started: May 18, 2016 · Completed: Mar 10, 2017